Alzheimer's disease: synaptic dysfunction and Aβ

被引:367
|
作者
Shankar, Ganesh M. [1 ,2 ]
Walsh, Dominic M. [3 ]
机构
[1] Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Lab Neurodegenerat Res, Dublin 4, Ireland
来源
关键词
LONG-TERM POTENTIATION; MILD COGNITIVE IMPAIRMENT; SOLUBLE AMYLOID OLIGOMERS; PROTEIN TRANSGENIC MICE; TG2576 MOUSE MODEL; RAT DENTATE GYRUS; HIPPOCAMPAL-NEURONS; PLAQUE-FORMATION; MOLECULAR-BASIS; IN-VIVO;
D O I
10.1186/1750-1326-4-48
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Synapse loss is an early and invariant feature of Alzheimer's disease (AD) and there is a strong correlation between the extent of synapse loss and the severity of dementia. Accordingly, it has been proposed that synapse loss underlies the memory impairment evident in the early phase of AD and that since plasticity is important for neuronal viability, persistent disruption of plasticity may account for the frank cell loss typical of later phases of the disease. Extensive multi-disciplinary research has implicated the amyloid beta-protein (A beta) in the aetiology of AD and here we review the evidence that non-fibrillar soluble forms of A beta are mediators of synaptic compromise. We also discuss the possible mechanisms of A beta synaptotoxicity and potential targets for therapeutic intervention.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Synaptic Dysfunction in Alzheimer's Disease
    Marcello, Elena
    Epis, Roberta
    Saraceno, Claudia
    Di Luca, Monica
    SYNAPTIC PLASTICITY: DYNAMICS, DEVELOPMENT AND DISEASE, 2012, 970 : 573 - 601
  • [2] Alzheimer's disease: synaptic dysfunction and Aβ
    Ganesh M Shankar
    Dominic M Walsh
    Molecular Neurodegeneration, 4
  • [3] The Role of Synaptic Dysfunction in Alzheimer's Disease
    Pei, Yixuan
    Davies, Julie
    Zhang, Melanie
    Zhang, Han-Ting
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 76 (01) : 49 - 62
  • [4] Alzheimer's disease:: Aβ, tau and synaptic dysfunction
    LaFerla, FM
    Oddo, S
    TRENDS IN MOLECULAR MEDICINE, 2005, 11 (04) : 170 - 176
  • [5] Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease
    Tu, Shichun
    Okamoto, Shu-ichi
    Lipton, Stuart A.
    Xu, Huaxi
    MOLECULAR NEURODEGENERATION, 2014, 9 : 48
  • [6] Targeting Synaptic Dysfunction in Alzheimer’s Disease Therapy
    Robert Nisticò
    Marco Pignatelli
    Sonia Piccinin
    Nicola B. Mercuri
    Graham Collingridge
    Molecular Neurobiology, 2012, 46 : 572 - 587
  • [7] Alzheimer's disease, amyloid peptide and synaptic dysfunction
    Hemar, Agnes
    Mulle, Christophe
    M S-MEDECINE SCIENCES, 2011, 27 (8-9): : 733 - 736
  • [8] Targeting Synaptic Dysfunction in Alzheimer's Disease Therapy
    Nistico, Robert
    Pignatelli, Marco
    Piccinin, Sonia
    Mercuri, Nicola B.
    Collingridge, Graham
    MOLECULAR NEUROBIOLOGY, 2012, 46 (03) : 572 - 587
  • [9] Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease
    Tonnies, Eric
    Trushina, Eugenia
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 57 (04) : 1105 - 1121
  • [10] Redox driven synaptic dysfunction in Alzheimer's disease
    Ravindranath, Viji
    FREE RADICAL BIOLOGY AND MEDICINE, 2019, 139 : S2 - S2